Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Procopio, M.
1998.
Sulpiride augmentation on schizophrenia.
British Journal of Psychiatry,
Vol. 172,
Issue. 5,
p.
449.
Soares, Bernardo GO
Fenton, Mark
and
Chue, Pierre
1999.
Sulpiride for schizophrenia.
Cochrane Database of Systematic Reviews,
Fleischhacker, W. Wolfgang
1999.
The psychopharmacology of schizophrenia.
Current Opinion in Psychiatry,
Vol. 12,
Issue. 1,
p.
53.
Fleischhacker, W. W.
1999.
Search for the Causes of Schizophrenia.
p.
331.
Carvajal, Alfonso
and
Martín Arias, Luis H.
1999.
Vol. 22,
Issue. ,
p.
45.
Raskin, Sergey
Durst, Rimona
Katz, Gregory
and
Zislin, Josef
2000.
Olanzapine and Sulpiride: A Preliminary Study of Combination/Augmentation in Patients With Treatment-Resistant Schizophrenia.
Journal of Clinical Psychopharmacology,
Vol. 20,
Issue. 5,
p.
500.
Procyshyn, Ric M.
and
Kennedy, Nathan B.
2000.
Theoretical Basis for Loxapine Augmentation in Risperidone Partial Responders.
Clinical Drug Investigation,
Vol. 19,
Issue. 4,
p.
257.
Wolfgang Fleischhacker, W
and
Marksteiner, Josef
2000.
Neurotransmitter Receptors in Actions of Antipsychotic Medications.
Vol. 20000744,
Issue. ,
p.
243.
Haw, Camilla
Stubbs, Jean
and
Mountjoy, Christopher
2000.
A survey of clozapine prescribing for inpatients in a tertiary psychiatric hospital.
Irish Journal of Psychological Medicine,
Vol. 17,
Issue. 3,
p.
91.
Frangou, S
and
Lewis, M
2000.
Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service.
European Psychiatry,
Vol. 15,
Issue. 3,
p.
220.
Fleischhacker, W. W.
2000.
Psychiatrie der Gegenwart 5.
p.
209.
Witz, S.
Kosov, I.
Assael-Amini, M.
and
Abramovich, Y.
2000.
A more favorable clinical outcome with sulpiride augmentation in a patient with chronic schizophrenia partially responsive to Olanzapine.
European Neuropsychopharmacology,
Vol. 10,
Issue. ,
p.
284.
&NA;
2000.
Is there a place for antipsychotic polypharmacotherapy in schizophrenia?.
Drugs & Therapy Perspectives,
Vol. 16,
Issue. 3,
p.
9.
Fleischhacker, W. W.
2001.
Contemporary Psychiatry.
p.
1509.
Conley, Robert R.
and
Kelly, Deanna L.
2001.
Treatment of the special patient with schizophrenia.
Dialogues in Clinical Neuroscience,
Vol. 3,
Issue. 2,
p.
123.
Goff, Donald C.
Freudenreich, Oliver
and
Evins, A. Eden
2001.
Augmentation Strategies in the Treatment of Schizophrenia.
CNS Spectrums,
Vol. 6,
Issue. 11,
p.
904.
Buckley, Peter F.
Wiggins, Lisa D.
Sebastian, Simon
and
Singer, Beth
2001.
Treatment-refractory schizophrenia.
Current Psychiatry Reports,
Vol. 3,
Issue. 5,
p.
393.
2001.
Letters to the Editor.
The Canadian Journal of Psychiatry,
Vol. 46,
Issue. 1,
p.
86.
Procyshyn, Ric M
Kennedy, Nathan B
Tse, Gordon
and
Thompson, Barbara
2001.
Antipsychotic Polypharmacy: A Survey of Discharge Prescriptions from a Tertiary Care Psychiatric Institution.
The Canadian Journal of Psychiatry,
Vol. 46,
Issue. 4,
p.
334.
Conley, Robert R.
and
Kelly, Deanna L.
2001.
Management of treatment resistance in schizophrenia.
Biological Psychiatry,
Vol. 50,
Issue. 11,
p.
898.
eLetters
No eLetters have been published for this article.